WBR1107: Difference between revisions

Jump to navigation Jump to search
No edit summary
Sergekorjian (talk | contribs)
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=William J Gibson
|QuestionAuthor=William J Gibson (Reviewed by {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|MainCategory=Pathology, Pathophysiology, Pharmacology
|MainCategory=Pharmacology
|SubCategory=Hematology, Pulmonology
|SubCategory=Pulmonology
|Prompt=A 35-year old man with HIV and documented trimethoprim-sulfamethoxazole allergy is placed on dapsone for pneumocystis prophylaxis after his CD4 count drops below 200/mm3. 3 weeks later, the patient presents to the emergency room with a 12-hour history of dyspnea, headache, dizziness and blue discoloration of the lips and extremities.   Pulse oximetry reveals an oxygen saturation of 82% on room air.  When blood is drawn for arterial-blood gas measurement, the nurse notices that it has a chocolate-brown color.  Which of the following would be the most effective pharmacotherapy?
|Prompt=A 35-year-old man with HIV and documented trimethoprim-sulfamethoxazole allergy is placed on dapsone for pneumocystis prophylaxis when his CD4 count dropped below 200/mm3. Three weeks later, the patient presents to the emergency department with a 12-hour history of dyspnea, headache, dizziness, and blue discoloration of the lips and extremities. Pulse oximetry reveals an oxygen saturation of 82% on room air.  When blood is drawn for arterial blood gas measurement, the nurse notices that it has a chocolate-brown color.  Which of the following would be the most effective pharmacotherapy to manage this patient's condition?
|Explanation=Methemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin (metHb, i.e., ferric [Fe3+] rather than ferrous [Fe2+] haemoglobin) in the blood. Methemoglobin is a form of hemoglobin that contains ferric [Fe3+] iron and has a decreased ability to bind oxygen.
|Explanation=[[Methemoglobinemia]] is a disorder characterized by the presence of a higher than normal concentration of methemoglobin (metHb, i.e., ferric [Fe3+] rather than ferrous [Fe2+] haemoglobin) in the blood. Methemoglobin is a form of hemoglobin that contains ferric [Fe3+] iron and has a decreased ability to bind oxygen. Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution (10 mg/ml) 1 to 2 mg/kg administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. This is achieved by providing an artificial electron acceptor (such as methylene blue or flavin) for NADPH methemoglobin reductase (methylene blue allows the enzyme to be five-fold more active). The NADPH is generated via the hexose monophosphate shunt.
 
Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution (10 mg/ml) 1 to 2 mg/kg administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state.
This is achieved by providing an artificial electron acceptor (such as methylene blue, or flavin) for NADPH methemoglobin reductase (RBCs usually don't have one; the presence of methylene blue allows the enzyme to function at 5x normal levels) The NADPH is generated via the hexose monophosphate shunt.
|AnswerA=Methylene blue
|AnswerA=Methylene blue
|AnswerAExp=Methylene blue can be used to reverse methemoglobinemia.
|AnswerAExp=Methylene blue reverses methemoglobinemia.
|AnswerB=Thiosulfate
|AnswerB=Thiosulfate
|AnswerBExp=Thiosulfate can be used to reverse methomglobinemia when cyanide poisoning is the cause.  However, in this case Dapsone was responsible for this patient’s methomglobinemia.
|AnswerBExp=Thiosulfate reverses methomglobinemia in cases of cyanide poisoning.  However, in this case dapsone pharmacotherapy was responsible for this patient’s methomglobinemia.
|AnswerC=N-acetyl-cysteine
|AnswerC=N-acetylcysteine
|AnswerCExp=N-acetyl-cysteine is used to reverse the toxicity of acetaminophen overdose.
|AnswerCExp=N-acetylcysteine reverses the toxicity of acetaminophen overdose.
|AnswerD=Naloxone
|AnswerD=Naloxone
|AnswerDExp=Naloxone is used to reverse the effects of opiate overdose.
|AnswerDExp=Naloxone reverses the effects of opiate overdose.
|AnswerE=Vitamin C
|AnswerE=Vitamin C
|AnswerEExp=Vitamin C can be effective in treating methemoglobinemia, but it is considered an ancillary therapy.
|AnswerEExp=Vitamin C can be effective in treating methemoglobinemia, but it is considered an ancillary therapy.
|EducationalObjectives=Methemoglobinemia is most effectively treated with methylene blue.
|EducationalObjectives=Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state.  
|References=First Aid 2015 page 604<br>
|References=First Aid 2015 page 604.
First Aid 2014 page 597
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Methemoglobinemia, Cyanosis, Blood, Oxygen, Pulmonary, Breathing, Lung, Hemoglobin,
|WBRKeyword=Methemoglobinemia, Cyanosis, Blood, Oxygen, Pulmonary, Breathing, Lung, Hemoglobin
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 00:08, 17 August 2015

 
Author [[PageAuthor::William J Gibson (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Pulmonology
Prompt [[Prompt::A 35-year-old man with HIV and documented trimethoprim-sulfamethoxazole allergy is placed on dapsone for pneumocystis prophylaxis when his CD4 count dropped below 200/mm3. Three weeks later, the patient presents to the emergency department with a 12-hour history of dyspnea, headache, dizziness, and blue discoloration of the lips and extremities. Pulse oximetry reveals an oxygen saturation of 82% on room air. When blood is drawn for arterial blood gas measurement, the nurse notices that it has a chocolate-brown color. Which of the following would be the most effective pharmacotherapy to manage this patient's condition?]]
Answer A AnswerA::Methylene blue
Answer A Explanation AnswerAExp::Methylene blue reverses methemoglobinemia.
Answer B AnswerB::Thiosulfate
Answer B Explanation AnswerBExp::Thiosulfate reverses methomglobinemia in cases of cyanide poisoning. However, in this case dapsone pharmacotherapy was responsible for this patient’s methomglobinemia.
Answer C AnswerC::N-acetylcysteine
Answer C Explanation AnswerCExp::N-acetylcysteine reverses the toxicity of acetaminophen overdose.
Answer D AnswerD::Naloxone
Answer D Explanation AnswerDExp::Naloxone reverses the effects of opiate overdose.
Answer E AnswerE::Vitamin C
Answer E Explanation AnswerEExp::Vitamin C can be effective in treating methemoglobinemia, but it is considered an ancillary therapy.
Right Answer RightAnswer::A
Explanation [[Explanation::Methemoglobinemia is a disorder characterized by the presence of a higher than normal concentration of methemoglobin (metHb, i.e., ferric [Fe3+] rather than ferrous [Fe2+] haemoglobin) in the blood. Methemoglobin is a form of hemoglobin that contains ferric [Fe3+] iron and has a decreased ability to bind oxygen. Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution (10 mg/ml) 1 to 2 mg/kg administered intravenously slowly over five minutes followed by IV flush with normal saline. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state. This is achieved by providing an artificial electron acceptor (such as methylene blue or flavin) for NADPH methemoglobin reductase (methylene blue allows the enzyme to be five-fold more active). The NADPH is generated via the hexose monophosphate shunt.

Educational Objective: Methemoglobinemia can be treated with supplemental oxygen and methylene blue 1% solution. Methylene blue restores the iron in hemoglobin to its normal (reduced) oxygen-carrying state.
References: First Aid 2015 page 604.]]

Approved Approved::Yes
Keyword WBRKeyword::Methemoglobinemia, WBRKeyword::Cyanosis, WBRKeyword::Blood, WBRKeyword::Oxygen, WBRKeyword::Pulmonary, WBRKeyword::Breathing, WBRKeyword::Lung, WBRKeyword::Hemoglobin
Linked Question Linked::
Order in Linked Questions LinkedOrder::